Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer's stock declined over 50% due to reduced sales ... The remarkable improvement was driven by the strong performance of Pfizer's core portfolio, particularly its drugs that treat cancer ...

Pfizer’s recent earnings report dazzled investors, but not everything sparkles like it seems. Unusual items worth ₹1.7b ...

Many investors turn to Benjamin Graham's so-called “Graham number” to calculate the fair price of a stock. The Graham number ...

The stock's fall snapped a four-day winning streak.

UnitedHealth has dropped nearly 50% amid headwinds, but strong fundamentals, margin stability, and low valuation signal ...